Overview

A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections

Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the efficacy and safety between Mycamine and Itraconazole oral solution in preventing invasive fungal infections on autologous(malignant blood diseases) or allogeneic hematopoietic stem cell transplant patients
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Echinocandins
Hydroxyitraconazole
Itraconazole
Micafungin